Kiora Pharmaceuticals

KPRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.700 M

$2.64 +3.13%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$10.8K

Loss-making

Shares outstanding

4,424,387

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#425Phio PharmaceuticalsPHIO$12.1M
#426BioLineRxBLRX$11.8M
#427Kiora PharmaceuticalsKPRX$11.7M
#428BullFrog AIBFRG$10.9M
#429Lunai BioworksLNAI$10.9M

Where these numbers come from

Share counts and financials for Kiora Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.